Carolyn Anderson

Carolyn Anderson, Executive Vice President of Intellectual Property, Technology Transfer, Contracts & Principal BioAtla.

"Ms. Anderson was a member of the founding management team of Diversa Corporation (now Verenium) where she served as Vice President, Intellectual Property and Licensing, Director of Intellectual Property and Contracts, among other roles, over her 11 year tenure. Ms. Anderson led the company's intellectual property group from inception in 1994 to her departure in 2005, where she managed a portfolio of over 250 issued and 500 pending patents, and over 50 pending and issued trademarks worldwide. During that time she successfully led the company through multiple proceedings. In 2000, the Diversa management team achieved the most successful biotechnology IPO at that time, raising over $200 million in gross proceeds. The portfolio she managed at Diversa was cited by MIT Magazine as being in the top 10 in the world both in 2003 and 2004 across all industries based on citation frequency.

"In addition, during her tenure as the head of IP, Ms. Anderson was the IP lead in business negotiations that raised $300 million in committed funding from corporate partners that included Novartis, Syngenta, Dow, Merck, Dupont, Givaudan, and Cargill. Before joining Diversa Corporation, Ms. Anderson served in multiple roles at Stratagene Cloning Systems, a molecular biology company based in La Jolla, California, including in sales, marketing, product management and business development.

"Ms. Anderson earned her undergraduate degree at the University of California, San Diego in Biochemistry and Cell Biology, is a registered Patent Agent with the USPTO, and has published in the area of intellectual property concerning biodiversity access. In 2003, she was a nominee in the T Sector Magazine and BIOCOM BioFUSION award for the "Life Sciences In-House Legal Counsel of the Year". Currently she is the President and co-owner of Capia IP in San Diego, California that provides business based intellectual property advice and services to the life sciences industry. Carolyn and her team at Capia IP provide intellectual property and contract services for BioAtla in the area of protien evolution and engineering. She is also a principal of BioAtla."